Navigation Links
Improved Pharma Publishes Review Article in AAPS PharmSciTech
Date:6/11/2019

Improved Pharma LLC announces the publication of “Predictive and Accelerated Formulation Design Using Synchrotron Methods” in the July 2019 issue of AAPS PharmSciTech. The article was published online on April 29th, 2019. The authors are Stephen R. Byrn and Pamela A. Smith of Improved Pharma, along with Xiaoming Sean Chen of Purdue University.

The article is the most recent addition to a theme dedicated to “Team Science and Education for Pharmaceuticals: the NIPTE Model”. NIPTE, or The National Institute for Pharmaceutical Technology & Education, is a collaboration of academia and industry. The mission is to improve the way medicines are designed, developed and manufactured to meet the needs of patients in the 21st century.

Improved Pharma’s review article presents a predictive/accelerated formulation strategy that is ideally suited for poorly soluble solid oral drugs. The first step is to understand and leverage key material properties such as solubility, BCS classification, and the solid-state landscape. Next, amorphous forms and/or complexes are formed, which present a valuable way to ensure high exposure in preclinical studies. To fully characterize important structural information about these complexes, synchrotron-based pair distribution function (PDF) analysis is used. This powerful technique aids in anticipating/predicting stability. Over-reaching all activities is a Quality by Design approach focused on Learning before Doing, which emphasizes doing it right the first time to mitigate risks and reduce time to market.

Commented Improved Pharma’s COO, Dr. Pamela Smith, “It’s an exciting time to be working in this field. Combining synchrotron PDF analysis with formulation design has allowed us to do more than just understand the structure of the complexes. It has given us the ability to predict the relative stability of one formulation over another.”
Adds Improved Pharma’s CSO, Professor Stephen Byrn, “By using these new technologies, we are moving into a new golden age of pharmaceuticals where we can attack many of the most difficult and troublesome diseases.”

The publication is available online at: https://link.springer.com/article/10.1208/s12249-019-1375-2.

About Improved Pharma
Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Dr. Stephen Byrn and Sarah Byrn founded the company in 2006 after the successful acquisition of their first company, SSCI. Dr. Pamela Smith joined the company in 2018 after an 18-year tenure with SSCI. Improved Pharma offers services such as analytical testing, synchrotron-based formulation design, and expert consulting aiding the development and defense of intellectual property matters.

For more information about the techniques discussed in this article or about Improved Pharma’s services, please contact us at 1-765-463-9951 or info(at)improvedpharma(dot)com.

Read the full story at https://www.prweb.com/releases/improved_pharma_publishes_review_article_in_aaps_pharmscitech/prweb16352435.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging
2. Improved mouse model will accelerate research on potential Ebola vaccines, treatments
3. Improved electricity access has little impact on climate change
4. S-equol supplements associated with improved measures of reproductive health in postmenopausal women
5. Federal food program puts food on the table, but dietary quality could be improved
6. Plant variants point the way to improved biofuel production
7. Samtools CRAMS in support for improved compression formats
8. Developing an improved liposuction technique that melts fat
9. University of Toronto biologists pave the way for improved epilepsy treatments
10. New meta-analysis builds on the power of whey protein for improved body composition
11. Improved access to integrated biodiversity data for science, practice, and policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... ... May 22, 2019 , ... Leak Detection Associates (LDA), ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to ... (IPP) Ltd has been signed. The agreement will grant exclusive rights for ...
(Date:5/21/2019)... ... , ... Suvoda LLC , a SaaS provider of Interactive Response Technology ... of Inc. Magazine’s Best Workplaces for 2019, Inc.’s fourth annual ranking of the fast-growing ... hitting the newsstands on May 28, is the result of a comprehensive measurement of ...
(Date:5/21/2019)... ... 20, 2019 , ... The ASGCT Clinical Trials Finder is a ... the United States. Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable ... volunteered to assist in the development of the ASGCT Clinical Trials Finder ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... PINE BROOK, N.J. (PRWEB) , ... May 03, ... ... visual electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response ... signs of glaucoma. , By 2050, it is estimated that 6.3 million Americans ...
(Date:5/2/2019)... ... 02, 2019 , ... Researchers from Ambry Genetics ... U.S. insurer policies for genetic testing and the 2019 National Comprehensive Cancer Network ... cancer (HBOC). , Jill S. Dolinsky, director of clinical affairs at ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... research team that includes a chemical engineer at Worcester Polytechnic Institute (WPI) has ... may make it possible to manufacture isobutanol and other biofuels more economically. , ...
(Date:4/12/2019)... ... April 12, 2019 , ... An upcoming episode of Advancements ... innovative tools and devices being used to enhance cognitive skills. This episode is ... segment of Advancements will focus on Sound for Life, a neurotechnology company helping ...
Breaking Biology Technology: